These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacological adjuncts in the treatment of opiate dependence. Resnick RB Arch Invest Med (Mex); 1974; 5 SUPPL 1():235-44. PubMed ID: 4447422 [No Abstract] [Full Text] [Related]
3. Psychoactive drug crisis intervention. Wesson DR; Smith DE Curr Psychiatr Ther; 1976; 16():203-8. PubMed ID: 991630 [No Abstract] [Full Text] [Related]
4. A cyclazocine typology in opiate dependence. Resnick RB; Fink M; Freedman AM Am J Psychiatry; 1970 Mar; 126(9):1256-60. PubMed ID: 5413202 [No Abstract] [Full Text] [Related]
5. Rapid opiate detoxification. Assessment is needed to exclude certain patients before detoxification. Rumball D; Williams J BMJ; 1997 Sep; 315(7109):682. PubMed ID: 9310588 [No Abstract] [Full Text] [Related]
6. Antagonists to the battle. DiPalma JR RN; 1976 Nov; 39(11):95-6, 98. PubMed ID: 1049452 [No Abstract] [Full Text] [Related]
7. XXIX. The basis and possible utility of the use of opioid antagonists in the ambulatory treatment of the addict. Martin WR Res Publ Assoc Res Nerv Ment Dis; 1968; 46():367-77. PubMed ID: 5723804 [No Abstract] [Full Text] [Related]
8. The use of cyclazocine in the treatment of heroin addicts. Petursson ES; Preble E Dis Nerv Syst; 1970 Aug; 31(8):549-51. PubMed ID: 5471792 [No Abstract] [Full Text] [Related]
9. The use of drugs in the management of drug dependence. Eddy NB J Tenn Med Assoc; 1967 Mar; 60(3):269-73. PubMed ID: 6042204 [No Abstract] [Full Text] [Related]
10. Trial of naloxone imperative in children with unexplained reduced consciousness level. Arch Dis Child; 2008 Feb; 93(2):183. PubMed ID: 18209001 [No Abstract] [Full Text] [Related]
11. Pharmacologic factors in relapse and the possible use of the narcotic antagonists in treatment. Martin WR IMJ Ill Med J; 1966 Oct; 130(4):489-94. PubMed ID: 4380652 [No Abstract] [Full Text] [Related]
12. Treatment of drug dependence enters a new high technological era. Kleber HD Addiction; 2004 Nov; 99(11):1476-7. PubMed ID: 15500602 [No Abstract] [Full Text] [Related]
13. Emergency treatment of narcotic overdose. Sandoval RG; Wang RI Wis Med J; 1972 Sep; 71(9):220-2. PubMed ID: 5069124 [No Abstract] [Full Text] [Related]
14. Treatment of heroin dependence with opiate antagonists. Fink M; Zaks A; Resnick R; Freedman AM Curr Psychiatr Ther; 1970; 10():161-70. PubMed ID: 5507440 [No Abstract] [Full Text] [Related]
15. Narcotic antagonists in opiate dependence. Fink M Science; 1970 Sep; 169(3949):1005-6. PubMed ID: 4914724 [No Abstract] [Full Text] [Related]
16. [Propranolol in treatment of opiate drug addicts]. Retterstol N Tidsskr Nor Laegeforen; 1975 Sep; 95(25):1429-30. PubMed ID: 1162681 [No Abstract] [Full Text] [Related]
17. Buprenorphine and naloxone interactions in methadone maintenance patients. Mendelson J; Jones RT; Welm S; Brown J; Batki SL Biol Psychiatry; 1997 Jun; 41(11):1095-101. PubMed ID: 9146820 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological treatments for substance use disorders. Bailey KP J Psychosoc Nurs Ment Health Serv; 2004 Aug; 42(8):14-20. PubMed ID: 15354595 [No Abstract] [Full Text] [Related]
19. Recent advances against substance abuse. Heading CE IDrugs; 2003 Jul; 6(7):681-7. PubMed ID: 12861473 [TBL] [Abstract][Full Text] [Related]
20. Behavioral health issue brief: pharmacotherapy treatment of alcoholism and drug addiction: overview and bibliography: year end report-2002. Colker AC Issue Brief Health Policy Track Serv; 2002 Dec; ():1-6. PubMed ID: 12875273 [No Abstract] [Full Text] [Related] [Next] [New Search]